Oncopeptides AB (publ)
Company

Oncopeptides AB (publ)

Pharmaceutical Manufacturing Stockholm, Stockholms Län, Se 83 employees ONCO
Employees
83
Contacts
4
Emails
4

Oncopeptides AB (publ) Overview

Headquarters
Stockholm, Stockholms Län, Se
Industry
Pharmaceutical Manufacturing
Employees
83
Founded
2000
Stock Symbol
ONCO
Funding
,
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Oncopeptides AB (publ)

Oncopeptides is a Swedish biotech company focusing on research, development and commercialization of targeted therapies for difficult-to-treat cancers. The company uses its proprietary Peptide Drug Conjugate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. Its flagship drug, Pepaxti, is currently being commercialized in Europe with partnership agreements for South Korea, the Middle East and Africa and elsewhere. Oncopeptides is also developing several new compounds based on its two proprietary technology platforms PDC and SPiKE. The company was founded in 2000, has about 80 employees with operations in Sweden, Germany, Austria, Spain and Italy. Oncopeptides is listed on Nasdaq Stockholm with the ticker ONCO. For more information, visit: www.oncopeptides.com

Oncopeptides AB (publ) Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage

Oncopeptides AB (publ) Org Chart

Sample employees and titles
Name Title Contact
Lotta Svensson Group Accounting Director
Email
Ida Nordberg Business Controller at Oncopeptides
Email
Sara Jarefors Clinical Scientist På Oncopeptides Ab
Email
Ulrica Westermark Biology Director at Oncopeptides
Email

Employees by Management Level

Director 2 profiles
Individual contributor 2 profiles

Compare Similar Companies to Oncopeptides AB (publ)